These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 17545858)

  • 41. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer.
    Dillman RO; Seagren SL; Propert KJ; Guerra J; Eaton WL; Perry MC; Carey RW; Frei EF; Green MR
    N Engl J Med; 1990 Oct; 323(14):940-5. PubMed ID: 2169587
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Radiation-chemotherapy interactions in limited small cell lung cancer.
    Livingston RB
    Front Radiat Ther Oncol; 1992; 26():72-82. PubMed ID: 1324878
    [No Abstract]   [Full Text] [Related]  

  • 43. [Current drug therapy of bronchial cancer].
    Drings P
    Verh Dtsch Ges Inn Med; 1990; 96():228-41. PubMed ID: 1965460
    [No Abstract]   [Full Text] [Related]  

  • 44. The potential role of surgery after induction treatment.
    Grunenwald DH; Albain KS
    Semin Radiat Oncol; 2004 Oct; 14(4):335-9. PubMed ID: 15558509
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Combined modality treatment of chemotherapy and radiotherapy for unresectable non-small cell lung cancer].
    Kubota K
    Gan To Kagaku Ryoho; 1997 Oct; 24 Suppl 3():384-9. PubMed ID: 9369912
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Does chemotherapy improve the results of postoperative radiotherapy in completely resected stage II and IIIA non-small-cell bronchial cancer?].
    Baumann M
    Strahlenther Onkol; 2001 Apr; 177(4):220-1. PubMed ID: 11370558
    [No Abstract]   [Full Text] [Related]  

  • 47. Management of unresectable non-small cell carcinoma of the lung (NSCLC).
    Cox JD; Le Chevalier T; Arriagada R; Choy H; Curran WJ; Fukuoka M; Harper P; Komaki R; Le Pechoux C; Lievens Y; Rami-Porta R; Ready N; Sause W; Stuschke M; Thatcher N
    Lung Cancer; 2003 Dec; 42 Suppl 1():S15-6. PubMed ID: 14708518
    [No Abstract]   [Full Text] [Related]  

  • 48. [The results of combined treatment for stage III lung cancer including the use of intraoperative radiotherapy].
    Dobrodeev AIu; Zav'ialov AA; Tyzikov SA; Musabaeva LI
    Vopr Onkol; 2013; 59(5):606-10. PubMed ID: 24260889
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Concurrent cetuximab and radiotherapy after docetaxel-cisplatin induction chemotherapy in stage III NSCLC: satellite--a phase II study from the Swedish Lung Cancer Study Group.
    Hallqvist A; Wagenius G; Rylander H; Brodin O; Holmberg E; Lödén B; Ewers SB; Bergström S; Wichardt-Johansson G; Nilsson K; Ekberg L; Sederholm C; Nyman J
    Lung Cancer; 2011 Feb; 71(2):166-72. PubMed ID: 20541833
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Role of chemotherapy in non-small cell lung carcinoma].
    Giaccone G; Dingemans AM
    Ned Tijdschr Geneeskd; 1996 May; 140(21):1111-4. PubMed ID: 8692336
    [No Abstract]   [Full Text] [Related]  

  • 51. Re: Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non small-cell lung cancer.
    Leo F; De Pas T; Catalano G; Piperno G; Curigliano G; Solli P; Veronesi G; Petrella F; Spaggiari L
    J Natl Cancer Inst; 2007 Aug; 99(15):1210; author reply 1210-1. PubMed ID: 17652281
    [No Abstract]   [Full Text] [Related]  

  • 52. [Neoadjuvant combined therapy in stage IIIA if non-small-cell bronchial cancer].
    Thomas M; Rübe C; Semik M; Junker K; von Eiff M
    Dtsch Med Wochenschr; 1997 Aug; 122(33):993-8. PubMed ID: 9296933
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adjuvant chemotherapy for lung cancer.
    Ikhlaque N; Baumann MA
    N Engl J Med; 2004 Apr; 350(16):1681-3; author reply 1681-3. PubMed ID: 15084703
    [No Abstract]   [Full Text] [Related]  

  • 54. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
    Sonett JR; Suntharalingam M; Edelman MJ; Patel AB; Gamliel Z; Doyle A; Hausner P; Krasna M
    Ann Thorac Surg; 2004 Oct; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Postoperative chemotherapy for n2 non-small-cell lung cancer: conclusions are not black and white, but gray.
    Hanna NH; Einhorn LH
    J Clin Oncol; 2006 Dec; 24(35):5611-2; author reply 5612-3. PubMed ID: 17158549
    [No Abstract]   [Full Text] [Related]  

  • 56. [Treatment of small cell lung cancer].
    Ueoka H; Ohnoshi T
    Gan To Kagaku Ryoho; 1994 Nov; 21(15):2571-7. PubMed ID: 7979415
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Concurrent chemotherapy and thoracic irradiation in non-small cell lung cancer.
    Bonomi P; Reddy S; Faber LP
    Hematol Oncol Clin North Am; 1990 Dec; 4(6):1143-58. PubMed ID: 1962781
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Very low acute toxicity of three fractions per day accelerated radiotherapy given after induction chemotherapy and surgery in stage III non-small cell lung cancer.
    de Pas T; Catalano G; Pastorino U; de Braud F; Jereczek-Fossa B; Spaggiari L; Orecchi R
    Lung Cancer; 2000 Nov; 30(2):149-50. PubMed ID: 11185476
    [No Abstract]   [Full Text] [Related]  

  • 59. [Management of non-small-cell lung carcinoma (NSCLC) of stage III B].
    Koukourakis M
    Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S33-6. PubMed ID: 11924241
    [No Abstract]   [Full Text] [Related]  

  • 60. [Establishment and evaluation of a prognostic prediction model for patients after complete resection of non-small cell lung cancer and multidisciplinary therapy].
    Wei WD; Fu JH; Lin P; Li XD; Yang H; Rong TH; Chen LK
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):672-5. PubMed ID: 19173908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.